| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 09/12/2001 | CN1312712A Therapeutic composition based on flavonoids for use in treatment of tumours with cytotoxic agents |
| 09/11/2001 | US6288246 Reaction of hydroxylamine with alkylsilyl halide, hydrolysis with acid |
| 09/11/2001 | US6288242 Processes and intermediates for preparing substituted chromanol derivatives |
| 09/11/2001 | US6287798 Esculetin derivatives |
| 09/11/2001 | CA2057578C 1,4-disubstituted piperazines, process for their preparation and pharmaceutical compositions containing them |
| 09/09/2001 | CA2339613A1 Process for producing alpha-tocopherol acetate |
| 09/09/2001 | CA2339589A1 Process for the production of alpha-tocopherol acetate by condensation of trimethylhydroquinone with isophytol with recycling of an acetic catalyst solution |
| 09/07/2001 | WO2001064665A1 Chroman derivatives as estrogenic compounds |
| 09/07/2001 | WO2001064664A1 Reagents for the quantitation of active oxygen |
| 09/07/2001 | WO2001064646A2 Hydrazones and analogs as cholesterol lowering agents |
| 09/07/2001 | WO2001064230A1 Use of catechin for preventing or treating coronary restenosis |
| 09/07/2001 | WO2001055111A8 Biaryl compounds, their preparation and their use in therapy |
| 09/07/2001 | WO2000062765A3 ESTROGEN RECEPTOR-β LIGANDS |
| 09/07/2001 | CA2401558A1 Agent for measurement of reactive oxygen |
| 09/06/2001 | US20010020009 Using plant extract |
| 09/05/2001 | EP1129707A2 Methods for identifying and treating resistant tumors |
| 09/05/2001 | EP1128826A1 Chromone enteric release formulation |
| 09/05/2001 | EP1128825A1 A new composition |
| 09/05/2001 | EP0828733B1 Benzopyrans and pharmaceutical compositions containing them |
| 08/30/2001 | WO2001062781A2 Homogentisate phytyl transferase |
| 08/30/2001 | WO2001062755A1 Fluorescent probes for the quantitation of zinc |
| 08/30/2001 | WO2001062718A1 Benzamide derivative and use thereof |
| 08/30/2001 | US20010018530 Alzheimer's and Parkinson disease |
| 08/30/2001 | US20010018503 Labeling; monitoring concentration |
| 08/30/2001 | US20010018456 Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis |
| 08/30/2001 | US20010018435 Prohormones; chemical intermediate in steroid metabolism in humans |
| 08/30/2001 | DE10009002A1 A new homogentisatephytyltransferase protein encoded by the open reading frame slr1376 from Synechocystis species. PCC6803 is useful to provide transgenic plants producing vitamin E |
| 08/30/2001 | CA2401359A1 Fluorescent probe for zinc |
| 08/30/2001 | CA2400783A1 Homogentisate phytyl transferase |
| 08/29/2001 | EP1127573A1 Compostitions and methods for treating osteoporosis |
| 08/29/2001 | EP1127572A2 Use of flavones for treating cycloxygenase-2 mediated diseases |
| 08/29/2001 | EP0889877B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1070173C Benzoylaguanidine derivatives using as medicine |
| 08/28/2001 | US6281366 Radiation transparent articles |
| 08/28/2001 | US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied |
| 08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
| 08/23/2001 | WO2001060832A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 08/23/2001 | WO2001060827A1 Novel p-gp-inhibiting compounds |
| 08/23/2001 | WO2001060811A1 Chromene compound |
| 08/23/2001 | WO2001060390A1 New toralactone and its derivation and the use of decreasing blood-fat and losing weight |
| 08/23/2001 | WO2001060359A1 Physiologic activity of a benzopyran derivative originating from propolis |
| 08/23/2001 | WO2000067738A3 The use of a protein tyrosine kinase pathway inhibitor in the treatment of ocular disorders |
| 08/23/2001 | US20010016669 Novel process and intermediates |
| 08/22/2001 | EP1125944A1 Pluraflavin and derivatives thereof, process for making them as well as their use |
| 08/22/2001 | EP1125929A1 Method for making (-)-(2R,4S)-4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester |
| 08/22/2001 | EP1125582A2 Use of estrogen agonists / antagonists for the treatment of sexual dysfunction |
| 08/22/2001 | EP1124986A1 Nitrocoumarins for detecting all micro-organisms |
| 08/22/2001 | EP1124980A2 Method for the production of quercetin and isoquercetin derivatives |
| 08/22/2001 | EP1124824A1 Chromenone and chromanone derivatives as integrin inhibitors |
| 08/22/2001 | EP1124817A1 Method of preparing delta-9-tetrahydrocannabinol esters |
| 08/22/2001 | EP1124816A1 Products for body hygiene based on lapacho extracts containing quercitine, their preparation and use |
| 08/22/2001 | EP1124815A1 Method for producing luteolin and luteolin derivatives |
| 08/22/2001 | EP1124814A1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 08/22/2001 | EP1124564A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
| 08/22/2001 | CN1309655A Cyclic compounds useful in treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 08/22/2001 | CN1309631A Aminomethylcarboxylic acid derivs |
| 08/22/2001 | CN1309133A Neotoralactone, its derivatives and their application in reducing fat and lossing weight |
| 08/22/2001 | CN1309125A Composition of gambogic acid compounds with anticancer activity and its preparing process |
| 08/22/2001 | CN1069903C Method for extracting isoflavone from soybean |
| 08/21/2001 | US6277879 Calanolide analogues and methods of their use |
| 08/21/2001 | US6277859 Highly selective kappa-opioid agonists useful as analgesics and diuretics with reduced physiological side effects |
| 08/21/2001 | US6277570 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents |
| 08/16/2001 | WO2001058889A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 08/16/2001 | US20010014669 Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin |
| 08/16/2001 | EP1123933A1 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane as CNS active agent |
| 08/16/2001 | EP1123304A1 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor |
| 08/16/2001 | EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP1123267A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123096A1 Bioflavonoids as plasma high density lipoprotein level increasing agent |
| 08/15/2001 | CN1308624A Novel polyoxypropylenepolyoxyethylene vitamin E and preparation thereof |
| 08/15/2001 | CN1308623A Method of production of vitamin E |
| 08/15/2001 | CN1308609A Method of locking 1 & alpha, -OH of vitamin d compounds in axial orientation |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/15/2001 | CN1308077A Preparation process of exterified chroman compound |
| 08/15/2001 | CA2337381A1 Compositions and methods for treating osteoporosis |
| 08/14/2001 | US6274738 Carboxamide derivatives having aryl and thiazole rings |
| 08/14/2001 | CA2187591C Novel tertiary heterocyclic amines; process for preparing them and pharmaceutical compositions containing them |
| 08/14/2001 | CA2158484C Novel benzopyrane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057032A1 C10 ester substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001056607A1 Integrin expression inhibitors |
| 08/09/2001 | US20010012901 An amidino group linker |
| 08/09/2001 | US20010012854 Administering to the patient a diamide compound to induce apoptosis in tumor cells |
| 08/08/2001 | EP1122251A1 Chromene compounds |
| 08/08/2001 | EP1122250A1 A method of chromotagraphic isolation for vitamin E isomers |
| 08/08/2001 | EP1121931A1 Controlled release oral preparations of esculetin and its derivatives |
| 08/08/2001 | EP1121342A1 Diaminopropionic acid derivatives |
| 08/08/2001 | EP0906302B1 Enantiomer separation from chromane acid esters |
| 08/08/2001 | EP0695547B1 Immunomodulator, cell adhesion inhibitor, and agent for treating and preventing autoimmune diseases |
| 08/08/2001 | CN1307553A Process for solid phase synthesis of aldehyde ketone oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds |
| 08/08/2001 | CN1069323C Gaseous polymerization method |
| 08/07/2001 | US6271395 Substituted with an N-methyl benzene-acetamide and 1-pyrrolidinyl |
| 08/07/2001 | US6271342 Sugar-modified cytostatics |
| 08/07/2001 | US6271253 Cyclooxygenase inhibitors |
| 08/07/2001 | US6271180 Substituted phenyl keto enols as pesticides and herbicides |
| 08/07/2001 | US6270899 As curing agent for epoxy resin |
| 08/07/2001 | CA2015296C Pyranyl cyanoguanidine derivatives |
| 08/02/2001 | WO2001055111A1 Biaryl compounds, their preparation and their use in therapy |
| 08/02/2001 | WO2001055098A1 Palatable arginine compounds and uses thereof for cardiovascular health |